Stay updated on Early Ixekizumab Activity in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.

Latest updates to the Early Ixekizumab Activity in Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new revision label v3.3.4 replacing v3.3.3; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA Locations section is added that lists New York as a study site, replacing the former New York Locations entry. The HHS Vulnerability Disclosure section is removed and the revision label updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved a government funding status notice that previously appeared on this page; no study content, endpoints, or eligibility information were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page shows a revised layout with updated sections and visual banners, while the core study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Early Ixekizumab Activity in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.